Egyptian study maps Behçet's disease patterns in 30 patients
NCT ID NCT07157189
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will observe 30 people with Behçet's disease at a hospital in Upper Egypt to learn more about their symptoms, lab results, and treatments. Researchers will track how often key signs like mouth ulcers, genital sores, and eye inflammation occur. The goal is to better understand the disease in this region, not to test a new drug or therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could provide a clearer picture of how Behçet's disease presents and is managed in Upper Egypt, potentially guiding better local care.
What could go wrong
This is a small, observational study with only 30 participants, so findings may not apply to all patients. It does not test any new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHÇET'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.